Clinical Trials on Relapsing Forms of Multiple Sclerosis
Total 3549 results
-
TG Therapeutics, Inc.RecruitingA Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk (PROVIDE)Relapsing Multiple SclerosisUnited States
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustria
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; Göteborg University; University... and other collaboratorsRecruitingMultiple Sclerosis | Relapsing Multiple SclerosisNorway
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple SclerosisCzechia, Serbia, United States, Croatia, Bosnia and Herzegovina, Slovakia
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple SclerosisUnited States, Mexico, Hungary, China, Germany, Italy, Peru, Poland, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Tunisia, Netherlands, Argentina, Georgia, Hong Kong, Kenya, Dominican Republic, Finland, North Macedonia, Serb...
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple SclerosisUnited States, Puerto Rico
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple SclerosisChina
-
Genentech, Inc.Active, not recruitingMultiple Sclerosis, RelapsingUnited States, Puerto Rico, Kenya
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...EMD Serono Research & Development Institute, Inc.TerminatedRelapsing Multiple SclerosisUnited States, Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Colombia, Croatia, Czechia, Estonia, Finland, France, Georgia, Germany, Hong Kong, Hungary, India, Israel, Italy, Korea, Republic of, M... and more
-
SanofiActive, not recruitingRelapsing Multiple SclerosisSpain, United States, Mexico, Japan, Austria, Belarus, Bulgaria, Canada, China, Czechia, Denmark, Estonia, Finland, Germany, Italy, Lithuania, Poland, Romania, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, Hong Kong
-
Loxo Oncology, Inc.Eli Lilly and CompanyWithdrawnMultiple Sclerosis | Relapsing Multiple SclerosisUnited States, Puerto Rico
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Belgium, Czechia, Russian Federation, Serbia, Spain, Italy, Netherlands, Finland, Estonia, Brazil, France, Germany, Poland, Switzerland, Ukraine, Peru, Argentina, Lithuania, Slovakia, Portugal, Australia, Hungary, Tunisia, Bulgar... and more
-
Providence Health & ServicesBristol-Myers Squibb; Milton S. Hershey Medical CenterWithdrawnMultiple Sclerosis | Relapsing Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisUnited States
-
CelgeneCompletedRelapsing Multiple SclerosisSpain, United States, United Kingdom, Croatia, Serbia, Belarus, Hungary, Bulgaria, Poland, Italy, Ukraine, Greece, Belgium, Georgia, Bosnia and Herzegovina, Moldova, Republic of, Romania, Russian Federation, Slovakia, South Africa and more
-
Lawson Health Research InstituteTerminatedAutoimmune Diseases | Relapsing Multiple SclerosisCanada
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Croatia, Russian Federation, India, Spain, New Zealand, Canada, Belgium, Netherlands, Bulgaria, Serbia, Greece, Ukraine, Mexico, Georgia, Colombia, Germany, Poland, United Kingdom, Czech Republic, France, Chile, Romania, Eston... and more
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompletedRelapsing Multiple SclerosisUnited Kingdom
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
EMD SeronoCompletedThe REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial (REGARD-PGx)Relapsing Multiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyMerck Serono Limited, UKCompletedRelapsing Multiple SclerosisUnited Kingdom
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Statens Serum Institut; Copenhagen University Hospital... and other collaboratorsCompletedRelapsing Multiple SclerosisDenmark
-
University of Alabama at BirminghamNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis, Relapsing-Remitting | Sexual DysfunctionUnited States
-
EMD SeronoCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Kessler FoundationHackensack Meridian HealthRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Pontificia Universidade Católica do Rio Grande...Merck S.A., Brazil, an affiliate of Merck KGaA, Darmstadt, GermanyActive, not recruitingMultiple Sclerosis, Relapsing-RemittingBrazil
-
Massachusetts General HospitalGilead SciencesWithdrawnFatigue | Multiple Sclerosis, Relapsing-RemittingUnited States
-
University of NottinghamNational Multiple Sclerosis SocietyCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Cionic, Inc.RecruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Fundació Institut Germans Trias i PujolClinica Universidad de Navarra, Universidad de NavarraRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingSpain
-
Bristol-Myers SquibbRecruiting
-
Merck KGaA, Darmstadt, GermanyCompleted
-
University Hospital of Mont-GodinneSaint-Luc University HospitalRecruitingMultiple Sclerosis, Relapsing-RemittingBelgium
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
Kessler FoundationCelgene; Hackensack Meridian Health; St. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of NebraskaCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompleted
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingAustralia
-
Novo Cellular Medicine Institute LLPUnknownMultiple Sclerosis, Relapsing-RemittingIndia, Trinidad and Tobago
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingCanada
-
Novartis PharmaceuticalsNot yet recruitingMultiple Sclerosis, Relapsing-Remitting
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Nottingham Trent University; Sheffield Hospitals CharityRecruiting
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
University Hospital, Basel, SwitzerlandRecruitingMultiple Sclerosis, Relapsing-RemittingSwitzerland
-
RemeGen Co., Ltd.RecruitingMultiple Sclerosis, Relapsing-RemittingChina